Chimeric epitope vaccine against Leptospira interrogans infection and induced specific immunity in guinea pigs
BACKGROUND: Leptospirosis is an important reemerging zoonosis, with more than half a million cases reported annually, and is caused by pathogenic Leptospira species. Development of a universal vaccine is one of the major strategic goals to overcome the disease burden of leptospirosis. In this study, a chimeric multi-epitope protein-based vaccine was designed and tested for its potency to induce a specific immune response and provide protection against L. interrogans infection.
RESULTS: The protein, containing four repeats of six T- and B-cell combined epitopes from the leptospiral outer membrane proteins, OmpL1, LipL32 and LipL21, was expressed and purified. Western blot analysis showed that the recombinant protein (named r4R) mainly expressed in a soluble pattern, and reacted with antibodies raised in rabbit against heat-killed Leptospira and in guinea pigs against the r4R vaccine. Microscopic agglutination tests showed that r4R antisera was immunological cross-reactive with a range of Chinese standard reference strains of Leptospira belonging to different serogroups. In guinea pigs, the r4R vaccine induced a Th1-biased immune response, as reflected by the IgG2a/IgG1 ratio and cytokine production of stimulated splenocytes derived from immunized animals. Finally, r4R-immunized guinea pigs showed increased survival of lethal Leptospira challenges compared with PBS-immunized animals and tissue damage and leptospiral colonization of the kidney were reduced.
CONCLUSIONS: The multi-epitope chimeric r4R protein is a promising antigen for the development of a universal cross-reactive vaccine against leptospirosis.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
---|---|
Enthalten in: |
BMC microbiology - 16(2016), 1 vom: 14. Okt., Seite 241 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lin, Xu'ai [VerfasserIn] |
---|
Anmerkungen: |
Date Completed 01.06.2017 Date Revised 08.04.2022 published: Electronic Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM265279232 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM265279232 | ||
003 | DE-627 | ||
005 | 20231224211931.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2016 xx |||||o 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0884.xml |
035 | |a (DE-627)NLM265279232 | ||
035 | |a (NLM)27737644 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lin, Xu'ai |e verfasserin |4 aut | |
245 | 1 | 0 | |a Chimeric epitope vaccine against Leptospira interrogans infection and induced specific immunity in guinea pigs |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.06.2017 | ||
500 | |a Date Revised 08.04.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: Leptospirosis is an important reemerging zoonosis, with more than half a million cases reported annually, and is caused by pathogenic Leptospira species. Development of a universal vaccine is one of the major strategic goals to overcome the disease burden of leptospirosis. In this study, a chimeric multi-epitope protein-based vaccine was designed and tested for its potency to induce a specific immune response and provide protection against L. interrogans infection | ||
520 | |a RESULTS: The protein, containing four repeats of six T- and B-cell combined epitopes from the leptospiral outer membrane proteins, OmpL1, LipL32 and LipL21, was expressed and purified. Western blot analysis showed that the recombinant protein (named r4R) mainly expressed in a soluble pattern, and reacted with antibodies raised in rabbit against heat-killed Leptospira and in guinea pigs against the r4R vaccine. Microscopic agglutination tests showed that r4R antisera was immunological cross-reactive with a range of Chinese standard reference strains of Leptospira belonging to different serogroups. In guinea pigs, the r4R vaccine induced a Th1-biased immune response, as reflected by the IgG2a/IgG1 ratio and cytokine production of stimulated splenocytes derived from immunized animals. Finally, r4R-immunized guinea pigs showed increased survival of lethal Leptospira challenges compared with PBS-immunized animals and tissue damage and leptospiral colonization of the kidney were reduced | ||
520 | |a CONCLUSIONS: The multi-epitope chimeric r4R protein is a promising antigen for the development of a universal cross-reactive vaccine against leptospirosis | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Cross protection | |
650 | 4 | |a Leptospira | |
650 | 4 | |a Multi-epitope | |
650 | 4 | |a Outer membrane protein | |
650 | 4 | |a Vaccine | |
650 | 7 | |a Antibodies, Bacterial |2 NLM | |
650 | 7 | |a Antigens, Bacterial |2 NLM | |
650 | 7 | |a Bacterial Outer Membrane Proteins |2 NLM | |
650 | 7 | |a Bacterial Vaccines |2 NLM | |
650 | 7 | |a Cytokines |2 NLM | |
650 | 7 | |a Epitopes, B-Lymphocyte |2 NLM | |
650 | 7 | |a Epitopes, T-Lymphocyte |2 NLM | |
650 | 7 | |a Immunoglobulin G |2 NLM | |
650 | 7 | |a LipL21 protein, Leptospira interrogans |2 NLM | |
650 | 7 | |a LipL41 protein, Leptospira interrogans |2 NLM | |
650 | 7 | |a Lipoproteins |2 NLM | |
650 | 7 | |a Recombinant Fusion Proteins |2 NLM | |
650 | 7 | |a ompL1 protein, Leptospira |2 NLM | |
700 | 1 | |a Xiao, Guohui |e verfasserin |4 aut | |
700 | 1 | |a Luo, Dongjiao |e verfasserin |4 aut | |
700 | 1 | |a Kong, Liangliang |e verfasserin |4 aut | |
700 | 1 | |a Chen, Xu |e verfasserin |4 aut | |
700 | 1 | |a Sun, Dexter |e verfasserin |4 aut | |
700 | 1 | |a Yan, Jie |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t BMC microbiology |d 2001 |g 16(2016), 1 vom: 14. Okt., Seite 241 |w (DE-627)NLM111200865 |x 1471-2180 |7 nnns |
773 | 1 | 8 | |g volume:16 |g year:2016 |g number:1 |g day:14 |g month:10 |g pages:241 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 16 |j 2016 |e 1 |b 14 |c 10 |h 241 |